Latest News | Orchid Pharma Board Gives Go-ahead to Raise Rs 500 Crore

New Delhi, Dec 1 (PTI) Drug firm Orchid Pharma on Thursday said its board has approved to raise Rs 500 crore from institutional investors.

The company's board has approved a Qualified Institutional Placement (QIP) programme to raise Rs 500 crore, it said in a regulatory filing.

Also Read | 7th Pay Commission: HRA of Central Government Employees to Increase Soon? Know How Much Increment is Expected.

With this QIP, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 per cent stake in it by March 2023.

Post a successful turnaround of the Insolvency Bankruptcy Code case, the company has been on a growth spree, it said.

Also Read | Digi Yatra App: Your Face Can Be Boarding Pass at These Airports, Know How Paperless Entry Works.

On the back of a robust product launch pipeline and an agile management team, the company said it is poised to become an even stronger player in the Cephalosporin antibiotics space.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)